logo
Join/ Subscribe

Subscribe

We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox..


Safe and Secure

Free Articles

logo
Join/ Subscribe Us

Subscribe

We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox.





    We assure a spam-free experience. You can update your email preference or unsubscribe at any time and we'll never share your information without your consent. Click here for Privacy Policy.


    Safe and Secure

    Free Articles

    News-posts

    KnowledgeNile is the one of the emerging technology content marketing organizations. 

    Axle AI and Cloudian Introduce AI-powered Media Management Solution for Hybrid Cloud Environments
    Joint offering brings together highly scalable, industry-standard object storage and the power of AI to accelerate media management across on-premises and cloud environments SAN MATEO, Calif., April 02, 2024  -- Axle AI, Inc., the leader in providing AI-powered media search (NAB booth SL10061), and Cloudian, the leader in S3-compatible hybrid data lake platforms (NAB booth […]
    Wrap Technologies Launches “WrapAI™” Suite of Artificial Intelligence-Powered Functionality for Intrensic BWC and DEMS
    MIAMI, April 01, 2024  -- Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), the makers of BolaWrap and the innovative public safety solutions platform powered by artificial intelligence (“AI”), virtual reality and data, today announces the launch of its artificial intelligence product suite for its Wrap Intrensic Body-Worn Camera and Digital Evidence Management (DEMS) […]
    Rakovina Therapeutics
    Rakovina Therapeutics Announces Strategic Pivot to AI
    Company Leveraging Deep Docking AI Drug Discovery Platform VANCOUVER, British Columbia, March 27, 2024 -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina” or the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a strategic evolution in its business model […]
    Scroll to Top